SCHEMBL3161981

SCHEMBL3161981

CC(=O)NCCNc1nc(-c2ccc(Cl)cc2)nc(NCCNC(=O)/C=C/c2ccc(C(C)C)cc2)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
LMNA P02545 4/20 0.50
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
CYP1A2 P05177 3/20 0.43
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 3/20 0.42
ALOX12 P18054 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
NLRP3 Q96P20 1/20 0.41
POLB P06746 1/20 0.41
HDAC2 Q92769 1/20 0.40
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3161992 1.00 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2LMNAPKMHTT
SCHEMBL3161481 0.92 LMNA (0.53) ALDH1A1SMN1; SMN2LMNAPKMHTT
SCHEMBL3161484 0.92 LMNA (0.53) ALDH1A1SMN1; SMN2LMNAPKMHTT
SCHEMBL3155554 0.90 ADORA2A (0.51) ALDH1A1SMN1; SMN2LMNACYP1A2MEN1
SCHEMBL3155570 0.90 ADORA2A (0.51) ALDH1A1SMN1; SMN2LMNACYP1A2MEN1
SCHEMBL3163340 0.88 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2LMNAPKMHTT
SCHEMBL3163351 0.88 SMN1; SMN2 (0.51) ALDH1A1SMN1; SMN2LMNAPKMHTT
SCHEMBL3175441 0.83 ADORA2A (0.48) ALDH1A1LMNACYP1A2MEN1KMT2A
SCHEMBL3175430 0.83 ADORA2A (0.48) ALDH1A1LMNACYP1A2MEN1KMT2A
SCHEMBL3167813 0.83 ADORA2A (0.56) ALDH1A1SMN1; SMN2LMNANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed